Theralase Technologies Stock Buy Hold or Sell Recommendation
| TLT Stock | CAD 0.28 0.01 3.70% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Theralase Technologies is 'Strong Sell'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Theralase Technologies given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Theralase Technologies, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Theralase Technologies Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Theralase and provide practical buy, sell, or hold advice based on investors' constraints. Theralase Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Theralase |
Execute Theralase Technologies Buy or Sell Advice
The Theralase recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Theralase Technologies. Macroaxis does not own or have any residual interests in Theralase Technologies or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Theralase Technologies' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Insignificant | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Theralase Technologies Trading Alerts and Improvement Suggestions
| Theralase Technologies had very high historical volatility over the last 90 days | |
| Theralase Technologies has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 1.07 M. Net Loss for the year was (4.57 M) with profit before overhead, payroll, taxes, and interest of 628.17 K. | |
| Theralase Technologies has accumulated about 1.67 M in cash with (4.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Latest headline from news.google.com: Theralase Technologies Trading Up 14.3 percent - Still a Buy - MarketBeat |
Theralase Technologies Returns Distribution Density
The distribution of Theralase Technologies' historical returns is an attempt to chart the uncertainty of Theralase Technologies' future price movements. The chart of the probability distribution of Theralase Technologies daily returns describes the distribution of returns around its average expected value. We use Theralase Technologies price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Theralase Technologies returns is essential to provide solid investment advice for Theralase Technologies.
| Mean Return | 0.31 | Value At Risk | -7.41 | Potential Upside | 8.00 | Standard Deviation | 6.12 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Theralase Technologies historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Theralase Technologies Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | (4.7M) | (4.2M) | (2.2M) | (1.5M) | (1.3M) | (1.3M) | |
| Free Cash Flow | (4.6M) | (4.1M) | (5.2M) | (4.1M) | (3.7M) | (3.5M) | |
| Other Non Cash Items | 9.7K | 5.3K | 49.4K | 1.0M | 925.3K | 971.5K | |
| Capital Expenditures | 164.6K | 100.8K | 70.4K | 37.3K | 42.9K | 40.7K | |
| Net Income | (5.6M) | (4.4M) | (5.2M) | (4.6M) | (4.1M) | (3.9M) | |
| End Period Cash Flow | 7.9M | 3.7M | 1.5M | 43.9K | 50.5K | 48.0K | |
| Change To Inventory | 270.3K | (113.9K) | 80.7K | (172.7K) | (198.5K) | (188.6K) | |
| Depreciation | 272.3K | 276.2K | 313.2K | 286.1K | 329.0K | 175.5K | |
| Change To Netincome | 422.0K | 929.7K | 342.4K | 241.1K | 277.2K | 441.1K | |
| Investments | (164.6K) | (100.8K) | (70.4K) | (37.3K) | (42.9K) | (45.0K) |
Theralase Technologies Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Theralase Technologies or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Theralase Technologies' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Theralase stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.29 | |
β | Beta against Dow Jones | 0.22 | |
σ | Overall volatility | 6.22 | |
Ir | Information ratio | 0.04 |
Theralase Technologies Volatility Alert
Theralase Technologies is displaying above-average volatility over the selected time horizon. Theralase Technologies is a potential penny stock. Although Theralase Technologies may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Theralase Technologies. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Theralase instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Theralase Technologies Fundamentals Vs Peers
Comparing Theralase Technologies' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Theralase Technologies' direct or indirect competition across all of the common fundamentals between Theralase Technologies and the related equities. This way, we can detect undervalued stocks with similar characteristics as Theralase Technologies or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Theralase Technologies' fundamental indicators could also be used in its relative valuation, which is a method of valuing Theralase Technologies by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Theralase Technologies to competition |
| Fundamentals | Theralase Technologies | Peer Average |
| Return On Equity | -2.39 | -0.31 |
| Return On Asset | -0.82 | -0.14 |
| Operating Margin | (11.30) % | (5.51) % |
| Current Valuation | 68.13 M | 16.62 B |
| Shares Outstanding | 245.54 M | 571.82 M |
| Shares Owned By Insiders | 8.70 % | 10.09 % |
| Number Of Shares Shorted | 42.79 K | 4.71 M |
| Price To Earning | (9.79) X | 28.72 X |
| Price To Book | 31.86 X | 9.51 X |
| Price To Sales | 74.01 X | 11.42 X |
| Revenue | 1.07 M | 9.43 B |
| Gross Profit | 628.17 K | 27.38 B |
| EBITDA | (4.31 M) | 3.9 B |
| Net Income | (4.57 M) | 570.98 M |
| Cash And Equivalents | 1.67 M | 2.7 B |
| Cash Per Share | 0.01 X | 5.01 X |
| Total Debt | 386.88 K | 5.32 B |
| Current Ratio | 3.45 X | 2.16 X |
| Book Value Per Share | 0.01 X | 1.93 K |
| Cash Flow From Operations | (4.07 M) | 971.22 M |
| Short Ratio | 0.06 X | 4.00 X |
| Earnings Per Share | (0.02) X | 3.12 X |
| Target Price | 1.2 | |
| Beta | 1.35 | -0.15 |
| Market Capitalization | 66.3 M | 19.03 B |
| Total Asset | 3.28 M | 29.47 B |
| Retained Earnings | (63.24 M) | 9.33 B |
| Working Capital | 421.43 K | 1.48 B |
| Net Asset | 3.28 M |
Theralase Technologies Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Theralase . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Theralase Technologies Buy or Sell Advice
When is the right time to buy or sell Theralase Technologies? Buying financial instruments such as Theralase Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Theralase Technologies in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Small Blend Funds Thematic Idea Now
Small Blend Funds
Fund or Etfs that invest in stocks of small to mid-sized entities that have characteristics of both growth and value companies. The Small Blend Funds theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Small Blend Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Theralase Stock Analysis
When running Theralase Technologies' price analysis, check to measure Theralase Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theralase Technologies is operating at the current time. Most of Theralase Technologies' value examination focuses on studying past and present price action to predict the probability of Theralase Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theralase Technologies' price. Additionally, you may evaluate how the addition of Theralase Technologies to your portfolios can decrease your overall portfolio volatility.